Meanwhile, activation of the signaling pathway of insulin-like growth factors-1 (IGF-1) reversed ARHGAP10 overexpression regulated EMT in NSCLC cells. The gene discussed is ARHGAP10; the disease is non-small cell lung carcinoma.